The Risk of Hypersensitivity Associated With Biologic Use Among Medicare Patients With Rheumatoid Arthritis

Arthritis Care and Research - United States
doi 10.1002/acr.23141
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

Unmet Needs and Biologic Use Among Patients With Rheumatoid Arthritis in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Risk of Diabetes Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Receipt of Glucocorticoid Monotherapy Among Medicare Beneficiaries With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2014English

Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry

Arthritis Care and Research
Rheumatology
2016English

Aspirin Use in Rheumatoid Arthritis Patients With Increased Risk of Cardiovascular Disease

ISRN Rheumatology
2013English

Sense of Coherence Among Patients With Rheumatoid Arthritis

Pielegniarstwo XXI Wieku
Nursing
2017English

Disability Work Among Argentinean Patients With Rheumatoid Arthritis

Open Journal of Rheumatology and Autoimmune Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy